Page last updated: 2024-08-26

sr141716 and Astrocytosis

sr141716 has been researched along with Astrocytosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cahill, CM; Grenier, P; Olmstead, MC; Wiercigroch, D	1
Cabral, GA; Hu, S; Lokensgard, JR; Min, X; Peterson, PK; Sheng, WS	1

Other Studies

2 other study(ies) available for sr141716 and Astrocytosis

Article	Year
Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists. Behavioural pharmacology, 2018, Volume: 29, Issue:2 and 3-Sp Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine	2018
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia, 2005, Jan-15, Volume: 49, Issue:2 Topics: Astrocytes; Benzoxazines; Camphanes; Cells, Cultured; Chemokines; Down-Regulation; Encephalitis; Gliosis; Humans; Inflammation Mediators; Interleukin-1; Morpholines; Naphthalenes; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Tumor Necrosis Factor-alpha	2005

Article

Year

Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.

Behavioural pharmacology, 2018, Volume: 29, Issue:2 and 3-Sp

Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine

2018

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes.

Glia, 2005, Jan-15, Volume: 49, Issue:2

Topics: Astrocytes; Benzoxazines; Camphanes; Cells, Cultured; Chemokines; Down-Regulation; Encephalitis; Gliosis; Humans; Inflammation Mediators; Interleukin-1; Morpholines; Naphthalenes; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Tumor Necrosis Factor-alpha

2005